#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Robert Herbst Email
VP . ImmunoGen
Waltham, MA
LocationPrimary Email
How to contact Robert Herbst
Join and see Robert's contact info for free!Current Roles
Employees:
378Revenue:
$127.7MAbout
Targeting a better life for people with cancer is why we get up in the morning. It's not enough to disrupt the progress of someone's cancer; we want to keep cancer from disrupting someone's life. That's why everything we do is about developing the most precise, targeted cancer therapies. We believe this is the best way to get people back to their livesback to living today, tomorrow, and beyond. Because for us, targeting a better now is the only thing that matters. We are a clinical-stage biotechnology company that develops targeted cancer therapeutics using antibody-drug conjugate (ADC) technology. Our lead product candidate, mirvetuximab soravtansine, is in Phase 3 study for FR-positive platinum-resistant ovarian cancer, and Phase 1b/2 testing in combination regimens. Our novel IGN candidates for hematologic malignancies, IMGN779 and IMGN632, are in Phase 1 studies. Learn more about who we are, what we do, and how we do it at www.immunogen.com.ImmunoGen Address
830 Winter StreetWaltham, MA
United States